![Christopher Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 369 809 $ al 30/06/2026
Christopher Roberts is currently Chief Financial Officer & Vice President at AC Immune SA since 2022 and Trustee & Treasurer at Msizi Africa.
Formerly, Mr. Roberts was Senior Manager at Ernst & Young SA (Geneva).
Education includes an undergraduate degree from the University of Lancaster.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AC IMMUNE SA 0,15 % | 18/03/2026 | 155.382 ( 0,15 % ) | 369 809 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AC IMMUNE SA | Director Financiero/CFO | 01/01/2022 |
Msizi Africa | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young SA (Geneva) | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
University of Lancaster
 University of Lancaster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young SA (Geneva) | |
Msizi Africa |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
